Drug profile · INN
disulfiram
DISULFIRAM
disulfiram (DISULFIRAM) is a aldehyde dehydrogenase inhibitor. Associated with Odyssey Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Drug details — disulfiram
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 3
- Programs
- 3
- Data quality
- 0.89
Quick answer
disulfiram (DISULFIRAM) is a aldehyde dehydrogenase inhibitor. Associated with Odyssey Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Aldehyde dehydrogenase inhibitor
Primary target: Aldehyde dehydrogenase, mitochondrial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is disulfiram?
disulfiram (DISULFIRAM) is a aldehyde dehydrogenase inhibitor. Associated with Odyssey Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for disulfiram?
DISULFIRAM is a marketed brand name for disulfiram. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of disulfiram?
disulfiram has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.